fbpx
Wednesday, September 28, 2022
Home Tags ViraTherapeutics

Tag: ViraTherapeutics

Boehringer Ingelheim acquires ViraTherapeutics for $245 million

Austrian biopharmaceutical company ViraTherapeutics specializes in the development of oncolytic viral therapies to fight cancer.
: